Hiscox Earnings Calls
| Release date | Feb 25, 2026 |
| EPS estimate | - |
| EPS actual | $2.18 |
| Revenue estimate | - |
| Revenue actual | 3.037B |
| Release date | Feb 25, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Aug 06, 2025 |
| EPS estimate | - |
| EPS actual | $1.31 |
| Revenue estimate | - |
| Revenue actual | 1.841B |
| Release date | Feb 27, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Hiscox
Below you can see how HCXLY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 27, 2025 |
| Price on release | $28.94 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Feb 21, 2025 | $26.62 |
| Feb 24, 2025 | $26.62 |
| Feb 25, 2025 | $27.53 |
| Feb 26, 2025 | $28.35 |
| Feb 27, 2025 | $28.94 |
| Feb 28, 2025 | $28.94 |
| Mar 03, 2025 | $29.69 |
| Mar 04, 2025 | $29.69 |
| Mar 05, 2025 | $30.15 |
| 4 days before | 8.72% |
| 4 days after | 4.18% |
| On release day | 1.11% |
| Change in period | 13.26% |
| Release date | Aug 06, 2025 |
| Price on release | $31.66 |
| EPS estimate | - |
| EPS actual | $1.31 |
| Date | Price |
|---|---|
| Jul 31, 2025 | $33.74 |
| Aug 01, 2025 | $36.26 |
| Aug 04, 2025 | $33.74 |
| Aug 05, 2025 | $31.66 |
| Aug 06, 2025 | $31.66 |
| Aug 07, 2025 | $37.19 |
| Aug 08, 2025 | $36.26 |
| Aug 11, 2025 | $37.19 |
| Aug 12, 2025 | $33.88 |
| 4 days before | -6.16% |
| 4 days after | 7.01% |
| On release day | 17.47% |
| Change in period | 0.415% |
| Release date | Feb 25, 2026 |
| Price on release | $41.00 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Feb 19, 2026 | $40.00 |
| Feb 20, 2026 | $40.00 |
| Feb 23, 2026 | $40.00 |
| Feb 24, 2026 | $40.00 |
| Feb 25, 2026 | $41.00 |
| Feb 26, 2026 | $41.00 |
| Feb 27, 2026 | $39.70 |
| Mar 02, 2026 | $39.70 |
| Mar 03, 2026 | $43.90 |
| 4 days before | 2.50% |
| 4 days after | 7.07% |
| On release day | 0% |
| Change in period | 9.75% |
| Release date | Feb 25, 2026 |
| Price on release | $41.00 |
| EPS estimate | - |
| EPS actual | $2.18 |
| Date | Price |
|---|---|
| Feb 19, 2026 | $40.00 |
| Feb 20, 2026 | $40.00 |
| Feb 23, 2026 | $40.00 |
| Feb 24, 2026 | $40.00 |
| Feb 25, 2026 | $41.00 |
| Feb 26, 2026 | $41.00 |
| Feb 27, 2026 | $39.70 |
| Mar 02, 2026 | $39.70 |
| Mar 03, 2026 | $43.90 |
| 4 days before | 2.50% |
| 4 days after | 7.07% |
| On release day | 0% |
| Change in period | 9.75% |
Hiscox Earnings Call Transcript Summary of Q4 2025
Hiscox delivered a strong 2025 driven by diversified, profitable growth and margin expansion. Group premiums rose by $275m (c.6% YoY) and the undiscounted combined ratio improved to 87.8% — the best in a decade — producing a record insurance service result and a record profit before tax ($733m) with an operating RoTE around 21%. Management announced a $300m share buyback and a 20% step-up in the final dividend, supported by robust capital generation (year-end estimated BSCR 233%, pro forma ~211%). Retail was the growth engine (ICWP +6.3%), with customer growth and product/distribution initiatives supporting guidance of 8% retail growth in 2026 and a target of double-digit retail growth by 2028. London Market and Reinsurance remain profitable (combined ratios in the 80s and 60s respectively), while cycle management and selective capital deployment continue. The change program delivered $29m of P&L benefit in 2025 and is on track for $75m in 2026 (targeting $200m by 2028). Management is actively adopting generative AI across customer/broker portals, underwriting and contact centers to drive efficiency and growth. Reserving is intentionally conservative (confidence level ~86% with $345m risk adjustment) and prior-year reserve releases were significant, reflecting favorable run-off. Key investor considerations: strong capital flexibility to fund growth and returns, clear retail growth trajectory underpinned by tech and distribution, continued underwriting discipline amid some softening rates in London and reinsurance, and execution risk on change program and AI rollouts.
Sign In
Buy HCXLY